Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines

Methods: A Companion to Methods in Enzymology

Volumn 19, Issue 1, 1999, Pages 103-107

  Baldridge, Jory R ^a   Crane, R Thomas ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; IMMUNOSTIMULATING AGENT; PHOSPHATIDYLCHOLINE; PHOSPHORYL LIPID A; POLYSORBATE 80; SQUALENE; TRIETHANOLAMINE; VACCINE;

DRUG FORMULATION; EMULSION; IMMUNIZATION; IMMUNOGENICITY; PRIORITY JOURNAL; REVIEW;

EID: 0032755036     PISSN: 10462023     EISSN: None     Source Type: Journal    
DOI: 10.1006/meth.1999.0834     Document Type: Article

References (31)

1. Greenberg L., Fleming D. S. Can. J. Public Health. 38:1947;279-282.
2. Landy M., Johnson A. G., Webster M. E., Sagin J. F. J. Immunol. 74:1955;466-478.
3. Webster M. E., Sagin J. F., Landy M., Johnson A. G. J. Immunol. 74:1955;455-465.
4. Landy M., Johnson A. G. Proc. Soc. Exp. Biol. Med. 90:1955;57-62.
5. Johnson A. G., Gaines S., Landy M. J. Exp. Med. 103:1956;225-246.
6. Galanos C., Lnderitz O., Rietschel E. T., Westphal O., Brade H., Brade L., Freudenberg M., Schade U., Imoto M., Yoshimura H. Eur. J. Biochem. 148:1985;1-5.
7. Takada H., Kotani S. Crit. Rev. Microbiol. 16:1989;477-523.
8. Ribi E. E., Strain S. M., Mizuno Y., Nowotny A., Von Eschen K. B., Cantrell J. L., McLaughlin C. A., Hwang K. M., Goren M., Parker R. Cancer Immunol. Immunother. 7:1979;43-58.
9. Takayama K., Ribi E., Cantrell J. L. Cancer Res. 41:1981;2654-2657.
10. Qureshi N., Takayama K., Ribi E. J. Biol. Chem. 257:1982;11808-11815.
11. Myers K. R., Truchot A. T., Ward J., Hudson Y., Ulrich J. T. Nowotny A., Spitzer J. J., Ziegler E. J. Cellular and Molecular Aspects of Endotoxin Reactions. 1990;145-156 Elsevier Science, Amsterdam.
12. Thoelen S., Van Damme P., Mathei C., Leroux-Roels G., Desombere I., Safary A., Vandepapeliere P., Slaoui M., Meheus A. Vaccine. 16:1998;708-714.
13. Stoute J. A., Slaoui M., Heppner D. G., Momin P., Kester K. E., Desmons P., Wellde B. T., Garcon N., Krzych U., Marchand M., Ballou W. R., Cohen J. D. N. Engl. J. Med. 336:1997;86-91.
14. Fries L. F., Gordon D. M., Richards R. L., Egan J. E., Hollingdale M. R., Gross M., Silverman C., Alving C. R. Proc. Natl. Acad. Sci. USA. 89:1992;358-362.
15. Ribi E., Takayama K., Cantrell J. L. Clin. Immunol. Newslett. 6:1985;33-48.
16. Masihi K. N., Lange W., Johnson A. G., Ribi E. J. Biol. Response Mod. 5:1986;462-469.
17. Arend W. P., Massoni R. J. Clin. Exp. Immunol. 64:1986;656-664.
18. Astiz M. E., Saha D. C., Carpati C. M., Rackow E. C. J. Lab. Clin. Med. 123:1994;89-93.
19. Henricson B. E., Benjamin W. R., Vogel S. N. Infect. Immun. 58:1990;2429-2437.
20. Carozzi S., Salit M., Cantaluppi A., Nasini M. G., Barocci S., Cantarella S., Lamperi S. J. Clin. Microbiol. 27:1989;1748-1753.
21. Cumberbatch M., Kimber I. Immunology. 75:1992;257-263.
22. Jonuleit H., Knop J., Enk A. H. Arch. Dermatol. Res. 289:1996;1-8.
23. Odean M. J., Frane C. M., Van derVieren M., Tomai M. A., Johnson A. G. Infect. Immun. 58:1990;427-432.
24. Gustafson G. L., Rhodes M. J. J. Immunother. Emphasis Tumor Immunol. 15:1994;129-133.
25. Schneerson R., Fattom A., Szu S. C., Bryla D., Ulrich J. T., Rudbach J. A., Schiffman G., Robbins J. B. J. Immunol. 147:1991;2136-2140.
26. Meyer T. J., Ribi E. E., Azuma I., Zbar B. J. Natl. Cancer Inst. 52:1974;103-111.
27. Ribi E. E., Meyer T. J., Azuma I., Parker R., Brehmer W. Cell. Immunol. 16:1975;1-10.
28. Murray R., Cohen P., Hardegree M. C. Ann. Allergy. 30:1972;146-151.
29. Newman M. J., Balusubramanian M., Todd C. W. Adv. Drug Del. Rev. 32:1998;199-223.
30. O'Hagan D. T., Singh M., Gupta R. K. Adv. Drug Del. Rev. 32:1998;225-246.
31. Kovacsovics-Bankowski M., Clark K., Benacerraf B., Rock K. L. Proc. Natl. Acad. Sci. USA. 90:1993;4942-4946.